SCHEMBL19860148

SCHEMBL19860148

C[C@H]1Cn2ncc(N3CC(c4ccc(F)nc4)OC3=O)c2CN1C(=O)Nc1cc(F)c(F)c(F)c1

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ FADS1 O60427 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17926115 0.92 AR (0.35) FADS1
SCHEMBL17926042 0.90 FADS1 (0.36) FADS1
SCHEMBL17926213 0.89 FADS1 (0.34) FADS1
SCHEMBL17925737 0.89 AR (0.35) —
SCHEMBL17926221 0.86 BACE1 (0.31) FADS1
SCHEMBL17925936 0.85 CHRM4 (0.33) —
SCHEMBL17926342 0.85 — —
SCHEMBL17925815 0.85 — —
SCHEMBL17926021 0.85 — —
SCHEMBL17926023 0.85 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9890167-B2 Pyrazine compounds for the treatment of infectious diseases HOFFMANN-LA ROCHE INC. (US) 2018-02-13 — — US disclosed
US-9890167-B2 Pyrazine compounds for the treatment of infectious diseases HOFFMANN-LA ROCHE INC. (US) 2018-02-13 — — US disclosed
Send feedback